Editas Medicine (EDIT) CFO Amy Parison Sells 453 Shares

What Happened Amy Parison, Chief Financial Officer of Editas Medicine (EDIT), reported the sale of 453 shares on 2026-09-03 at $3.04 per share, totaling $1,376. The sale was a disposition (S code) and was executed to satisfy tax withholding obligations tied to restricted stock units (RSUs) that vested on September 2, 2026. This was a non-discretionary, automatic sale rather than an ad hoc decision to liquidate holdings.

Key Details

• Transaction date and price: 2026-09-03, 453 shares sold at $3.04 each.
• Total proceeds: $1,376.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Sale effected under a durable automatic sales instruction plan adopted July 7, 2022; represents sale of issuer shares necessary for tax withholding on RSU vesting and was not a discretionary trade by the reporting person.
• Filing timeliness: Report filed 2026-09-04 for a 2026-09-03 transaction (appears timely).

Context This sale was for tax withholding on vested RSUs under an automatic plan, a routine administrative transaction common among executives and not a direct signal of personal trading intent. For retail investors, purchase transactions generally carry more informational weight than routine withholding sales.